at the same time, it boosts the bodys basal metabolic rate, accelerating the process of peripheral body energy consumption, and the two-pronged approach of burning excess fat, to achieve the goal of weight loss
doi: 10.3390/v12101179 185 MordesD
In the SURMOUNT-1 trial, participants on the highest dose of tirzepatide lost an average of 22.5 percent of their body weight at 72 weeks (Jastreboff et al., NEJM , 2022), compared to roughly 15 percent with semaglutide 2.4 mg in the STEP 1 trial (Wilding et al., NEJM , 2021)
The peptide's ability to upregulate growth factors, Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor (EGF), contributes directly to faster cellular rebuilding at injury sites, making it one of the more consistently studied compounds in tissue healing research